Consolidated Statements of Shareholders' Deficit - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Treasury Stock	Paid-in Capital	(Deficit)	Accumulated Other Comprehensive Loss, Net	Accelerated Share Repurchase 2016	Accelerated Share Repurchase 2016 Treasury Stock	Accelerated Share Repurchase 2018	Accelerated Share Repurchase 2018 Treasury Stock
Balance as of beginning period (in shares) at Dec. 28, 2016		107,115
Balance as of beginning period at Dec. 28, 2016	$ (71,112)	$ 1,071	$ (265,884)	$ 577,951	$ (382,843)	$ (1,407)
Balance as of beginning of period, treasury stock (in shares) at Dec. 28, 2016			(35,757)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	39,594				39,594
Other comprehensive loss	(909)					(909)
Share-based compensation on equity classified awards, net	$ 8,131			8,131
Purchase of treasury stock (in shares)	(6,800)		(6,840)				(500)	(554)
Purchase of treasury stock	$ (82,858)		$ (82,858)				$ (6,900)
Equity forward contract settlement			(6,884)	6,884
Issuance of common stock for share-based compensation (in shares)		398
Issuance of common stock for share-based compensation		$ 4		(4)
Exercise of common stock options (in shares)		227
Exercise of common stock options	655	$ 2		653
Balance as of ending period at Dec. 27, 2017	(97,360)	$ 1,077	$ (355,626)	594,166	(334,661)	(2,316)
Balance as of end of period (in shares) at Dec. 27, 2017		107,740
Balance as of end of period, treasury stock (in shares) at Dec. 27, 2017			(43,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	43,693				43,693
Other comprehensive loss	(1,830)					(1,830)
Share-based compensation on equity classified awards, net	$ 4,325			4,325
Purchase of treasury stock (in shares)	(3,900)		(3,901)
Purchase of treasury stock	$ (61,189)		$ (61,189)
Equity forward contract settlement	(6,763)			(6,763)
Issuance of common stock for share-based compensation (in shares)		447
Issuance of common stock for share-based compensation		$ 5		(5)
Exercise of common stock options (in shares)		398
Exercise of common stock options	1,225	$ 4		1,221
Balance as of ending period at Dec. 26, 2018	$ (133,345)	$ 1,086	$ (416,815)	592,944	(306,414)	(4,146)
Balance as of end of period (in shares) at Dec. 26, 2018	108,585	108,585
Balance as of end of period, treasury stock (in shares) at Dec. 26, 2018	(47,052)		(47,052)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 117,410				117,410
Other comprehensive loss	(29,814)					(29,814)
Share-based compensation on equity classified awards, net	3,310			3,310
Purchase of treasury stock (in shares)			(4,879)						(400)	(389)
Purchase of treasury stock	(96,202)		$ (96,202)						$ (6,800)
Equity forward contract settlement			(6,763)	6,763
Issuance of common stock for share-based compensation (in shares)		468
Issuance of common stock for share-based compensation		$ 5		(5)
Exercise of common stock options (in shares)		362
Exercise of common stock options	971	$ 3		968
Balance as of ending period at Dec. 25, 2019	$ (138,064)	$ 1,094	$ (519,780)	$ 603,980	$ (189,398)	$ (33,960)
Balance as of end of period (in shares) at Dec. 25, 2019	109,415	109,415
Balance as of end of period, treasury stock (in shares) at Dec. 25, 2019	(52,320)		(52,320)